A carregar...
DDIS-21. APPLICATION OF A FUNCTIONAL GENETICS APPROACH TO IDENTIFY PHARMACOLOGICAL INHIBITORS OF HIF-1α
Two phase III clinical trials with temozolomide (TMZ) in combination with bevacizumab for newly diagnosed glioblastoma multiforme (GBM) failed to demonstrate any survival benefit when compared to TMZ alone. Previous studies have shown that bevacizumab treatment increases intratumoral hypoxia followe...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692325/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.256 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|